Case Report: Practical approach to unmask unspecific adverse effects under lipid-lowering medication
The nocebo effect, driven by negative expectations rather than pharmacological mechanisms, contributes significantly to medication non-adherence, particularly in lipid-lowering therapy. Up to 50% of reported statin-related adverse effects may result from nocebo responses, leading to unnecessary disc...
Saved in:
| Main Authors: | Thomas Büttner, Gunther Hartmann, Martin Coenen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1604129/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of the nocebo effect on discontinuation of statin therapy due to myopathy in patients with cardiovascular disease – a review
by: Jakub Stanek, et al.
Published: (2024-11-01) -
Placebo and the law of identification
by: Steve F. Bierman, et al.
Published: (2024-12-01) -
Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case)
by: A. V. Melekhov, et al.
Published: (2025-06-01) -
Hypolipidemia: How Common Is It!!
by: Lydia W Jeris, et al.
Published: (2023-01-01) -
Pre-operative expectations in patients with endometriosis – a qualitative interview study
by: Nina Hirsing, et al.
Published: (2025-04-01)